Autophagy modulates the effects of bis-anthracycline WP631 on p53-deficient prostate cancer cells

Area of Science:

• Molecular Biology
• Cancer Research
• Pharmacology

Background:

• p53-deficient PC-3 human prostate carcinoma cells were investigated.
• Bis-anthracycline WP631 is a potential anti-cancer agent.
• 2-deoxy-D-glucose (2-DG) induces metabolic stress and autophagy.

Purpose of the Study:

• To investigate the effects of WP631 and 2-DG on gene expression, cell cycle, autophagy, and cell death in PC-3 cells.
• To determine if autophagy enhances the cytotoxicity of WP631.

Main Methods:

• Treatment of PC-3 cells with WP631 and/or 2-DG.
• Quantification of gene expression related to autophagy and apoptosis using real-time PCR.
• Analysis of cell cycle arrest, autophagy induction, and cell death mechanisms (necrosis and apoptosis).

Main Results:

• WP631 induced G2/M cell cycle arrest, autophagy, and cell death.
• 2-DG enhanced the antiproliferative effects of WP631.
• Autophagy induction was observed, preceding cell death, which occurred via necrosis and apoptosis.
• WP631 independently induced autophagy, enhancing its own cytotoxicity.

Conclusions:

• WP631 is an antiproliferative agent that inhibits gene transcription and induces autophagy.
• Autophagy enhances the cytotoxic activity of DNA-binding drugs like WP631.
• Combined treatment with WP631 and 2-DG shows potential for cancer therapy.